An interim analysis shows that erlotinib significantly extends progression-free survival in nonsmall-cell lung cancer (NSCLC) patients with EGFR mutations. Medscape Medical News
The role of anti-VEGF antibody treatment in advanced breast cancer is explored, with updates from recent studies. Therapeutic Advances in Medical Oncology
The US FDA has dropped a requirement that prescribers and patients enroll in a monitoring network to use Nplate and Promacta, among other changes. News Alerts
Dr. Messmore, a pioneer in hematologic research and anticoagulation therapy, has received a belated tribute from France for HIS heroism during World War II. Medscape Medical News